TOKYO, Oct. 8, 2024 /PRNewswire/ -- Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, "Ciconia") today announced its establishment as a joint venture company based on a ...
PARIS & LONDON--(BUSINESS WIRE)--Aqemia announces it is broadening and accelerating its computational platform to target RNAs using its physics-enabled generative AI engine. Building on successes in ...
Outlines broad discovery and development efforts targeting synthetic lethality and DNA-damage repair mechanisms, including PRMT5-MTA, SGR-3515 and SGR-2921 programs NEW YORK--(BUSINESS ...
NEW YORK, Feb. 3, 2026 /PRNewswire/ -- Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, has won the OpenADMET-ExpansionRx blind challenge with its Beacon models, placing ...
Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced an agreement with AbbVie to develop ...
Scientific progress often stalls not because of a lack of ideas, but because of a lack of material. Across drug discovery, agriculture, and industrial biotech, promising programs are delayed or ...
Invivyd, Inc. has launched a discovery program for a monoclonal antibody (mAb) targeting measles, following requests from healthcare providers for a treatment option for active infections and ...
Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an equity investment in Aitia as part of the ...
Mosaic Biosciences announces the addition of a Carterra (HT-SPR) instrument to its discovery platform for characterization and enhanced discovery capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results